Feed MAP.AX
MA
Microba Life Sciences Limited
MAP.AX · ASX
$0.06 +7.41% (+$0.00)
1M +22.73%
Market Cap $38.7M
P/E Ratio -
Div. Yield -
ROE 41.19%
Piotroski F-Score Weak
3/9Valuation
83 /100
Cheap P/B 1.19x
P/S 2.47x
EV/EBITDA N/A
Growth
82 /100
Growing Book val. growth 1.05%
Rev. growth 49.51%
FCF growth N/A
Profitability
19 /100
Weak Net margin 95.34%
Op. margin 157.05%
FCF margin 95.17%
Quality
4 /100
Poor ROE 41.19%
ROA 31.49%
Asset turnover 0.33x
Debt
68 /100
Low Current ratio 1.87x
Int. coverage -84.57x
Debt/Equity 0.10x
Stability
21 /100
Unstable Rev. volatility 58.42%
EPS volatility 29.53%
Profitable years 0
Întreabă StockBot despre MAP.AX
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Luke Reid
Employees
80
Headquarters
Brisbane
Evenimente viitoare
01 SEPT.
Earnings
Upcoming earnings report